Save Our Shots!
September 30, 2020
Immunization rates drop amidst the pandemic
1 min read
Sep
Manufacture
Bioprocessing - Single Use Systems
Bioprocessing - Upstream & Downstream
Advanced Medicine
Business Practice
Clinical Trials
Contract Development Services
Contract Manufacturing Services
Dosage Forms
Drug Delivery
Drug Discovery
Formulation
Small Molecules
Trends & Forecasts
Vaccines
Bioprocessing
Biopharma
Cell & Gene
Business & Trends
Development & Clinical
Outsourcing
Technology & Manufacturing
Formulation
Drug Delivery
Drug Discovery
Research News
Small Molecules
Sponsored
The Power List 2021: Nominate Now
September 30, 2020
Nominations are now open for The Medicine Maker 2021 Power List.
1 min read
Process Control
Analytical Science
Standards & Regulation
Regulation & Standards
Business & Trends
Sponsored
Focus on Quality – and the Rest Will Follow
September 29, 2020
Amgen developed the Multi-Attribute Method (MAM) to obtain high-fidelity understanding of the quality of its own biologics – which is raising the bar across the biopharmaceutical industry
0 min read
Process Control
Analytical Science
Standards & Regulation
Regulation & Standards
Business & Trends
Sponsored
Mapping Out MAM
September 29, 2020
Amgen has brought the Multi-Attribute Method (MAM) into the mainstream, but what’s next for this analytical workflow – and for biopharmaceutical QC?
0 min read
The Genomic Revolution
September 29, 2020
Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views.
1 min read
Transgenic Drug Discovery
September 28, 2020
A breakthrough in transgenic mice opens the door to “Humabodies.” Theodora Harold, CEO, and Brian McGuinness, Vice President, Business Development, both from Crescendo Biologics, provide background on the research and what it means for drug discovery.
1 min read
The Pandemic Diaries
September 23, 2020
We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis
1 min read
The Drug Dose Gender Gap
September 22, 2020
Does equal always mean fair?
1 min read
The Cell Therapy Guardians
September 18, 2020
We speak with Laertis Ikonomou, Chair of the ISCT PTF on the Use of Unproven and/or Unethical Cell & Gene Therapies, and Associate Professor of Oral Biology at the University at Buffalo, SUNY, and Dan Weiss, ISCT Chief Scientific Officer and Professor of Medicine at the University of Vermont, about the ISCT’s work to combat unproven cell therapies and its drive to ensure that studies into legitimate COVID-19 cell therapies rigorously demonstrate safety and efficacy.
1 min read
Great Expectations
September 17, 2020
The pressure is on for cell therapy manufacturers to meet the expectations of patients and peers alike. Though the therapeutic potential is significant, companies will have to reckon with substantial challenges to see long-lasting success. Here, we speak to Dennis Williams, Senior Vice President at Adaptimmune, about the roadblocks and opportunities the sector faces and how the company is working to address them.
1 min read
Browse by Topics
Interview
Drug Discovery
Development & Clinical
Formulation
Drug Delivery
Bioprocessing
Small Molecules
Cell & Gene
Facilities & Equipment
Outsourcing
Packaging
Supply Chain
Regulation & Standards
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blog